Mortality in intravascular large B-cell lymphoma: A SEER analysis

J Am Acad Dermatol. 2018 Dec;79(6):1163-1165. doi: 10.1016/j.jaad.2018.07.042. Epub 2018 Aug 6.

Authors

Amrita Goyal¹, Kavita Goyal², Kimberly Bohjanen³

Affiliations

¹ Department of Dermatology, University of Minnesota, Minneapolis, Minnesota. Electronic address: goyal046@umn.edu.
² Department of Dermatology, Drexel University, Philadelphia, Pennsylvania.
³ Department of Dermatology, University of Minnesota, Minneapolis, Minnesota.

PMID: 30092329
DOI: 10.1016/j.jaad.2018.07.042

No abstract available

MeSH terms

Adult
Aged
Aged, 80 and over
Cause of Death
Ethnicity / statistics & numerical data
Female
Humans
Immunotherapy
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse / drug therapy
Lymphoma, Large B-Cell, Diffuse / mortality*
Male
Middle Aged
Retrospective Studies
Rituximab / therapeutic use
SEER Program
United States / epidemiology
Vascular Neoplasms / drug therapy
Vascular Neoplasms / mortality*

Substances

Rituximab